Top 5 stories on injectable HIV treatment and PrEP from CROI 2024
Over 30 years, big fall in HIV among people who inject drugs in Baltimore, but hepatitis C remains high
Top 5 stories on HIV and women from CROI 2024
Top 5 HIV PrEP stories from CROI 2024
Long-acting injectables can be a good option for people with adherence challenges
Top 5 stories on co-morbidities affecting people with HIV from CROI 2024
Should event-driven PrEP be an option for women?
Nearly two million people in sub-Saharan Africa may have advanced HIV disease
Top 5 HIV treatment stories from CROI 2024
